ToxicologistUS FDA
Advances and Challenges in Oligonucleotide and mRNA Therapeutics: New Strategies and Regulatory Perspectives (S12)
Tuesday, November 19, 20242:00 PM - 5:00 PM CT
Safety Assessment of Oligonucleotides Administered via the Intrathecal Route (S12-5)
Tuesday, November 19, 20244:15 PM - 4:45 PM CT